恆大健康(0708.HK)連續第二日大漲 恆馳明年亮相 2021年量產
格隆匯11月14日丨繼昨日收漲10.52%後,恆大健康(0708.HK)今日再度大漲,現報9.06港元,漲9.16%,暫成交5790萬港元,最新總市值782.78億港元。該股兩日累漲超20%。

資料顯示,恆大健康主要業務為國際醫院、養老及康復產業,以及高科技新能源汽車製造投資,自2018年6月佈局新能源汽車以來,恆大監看在新能源汽車領域投資不斷。包括收購廣彙集團40.96%股份、93億美元收購瑞典NEVS 51%股份、10.6億元收購卡耐新能源58%股份、3億歐元入股科尼賽爾成立合資公司、5億元收購荷蘭e-Traction 70%股權、與國家電網設立合資公司、與德國Hofer設立合資公司等。
恆大集團董事局主席許家印近日表示,未來三年在造車方面的投資為450億元,依次為200億元、150億元與100億元。恆大集團的汽車品牌被命名為“恆馳”。許家印稱,恆馳品牌首款車型將於2020年上半年亮相,2021年實現量產。公司附屬NEVS旗下的全資子公司也正為集團的汽車品牌“恆馳”電動汽車進行研發工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.